Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$135.68 - $176.11 $119,534 - $155,152
881 Added 10.61%
9,186 $1.44 Million
Q2 2024

Aug 08, 2024

SELL
$72.62 - $150.62 $27,595 - $57,235
-380 Reduced 4.38%
8,305 $1.25 Million
Q1 2024

May 14, 2024

BUY
$70.86 - $89.93 $74,048 - $93,976
1,045 Added 13.68%
8,685 $642,000
Q4 2023

Mar 26, 2024

BUY
$36.74 - $81.08 $280,693 - $619,451
7,640 New
7,640 $603,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.1B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.